In a landmark breakthrough, scientists successfully used CRISPR gene editing to make pig organs compatible for human transplants. The edited organs reduced the risk of rejection and eliminated viral transmission concerns. In 2025, the first human patient received a gene-edited pig kidney that functioned normally for over 6 months.

This could solve the global organ shortage crisis. Ethical debates continue, but clinical results are promising. Medical experts believe this could lead to mass production of transplantable organs in the next decade, saving countless lives and reshaping transplant medicine forever.